All Stories

  1. Chronic granulomatous disease: A multicenter study from the MENA region
  2. Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations
  3. Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
  4. Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort
  5. Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution
  6. Global disparities in adrenaline access: A World Allergy Organization call for equity in anaphylaxis care
  7. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
  8. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
  9. Characterization of ambient air quality and its relationship with respiratory morbidity in typical cities of Northwest China (NWC)
  10. Case Report: Not all recurrent “idiopathic” anaphylaxis is idiopathic
  11. A World Allergy Organization (WAO) manifesto for the worldwide approval of biologic therapies for food allergy
  12. Unmet needs in hereditary angioedema: an international survey of physicians
  13. Defining Clinical Remission in Severe Asthma: Expert Opinion From the Gulf Region Using the Modified Delphi Method
  14. In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar
  15. Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
  16. Contact Urticaria and Related Conditions: Clinical Review
  17. WAO - ARIA consensus on chronic cough: Executive summary
  18. Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
  19. Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years
  20. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  21. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
  22. Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study
  23. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
  24. Etiology of bronchiectasis in Qatar: A retrospective study
  25. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
  26. The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up
  27. Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
  28. Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity– a multicentric retrospective cohort study from the Arabian Peninsula
  29. Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
  30. Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
  31. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system
  32. Uncovering a neurological protein signature for severe COVID-19
  33. A review of patch-test data over the period of eight years in the allergy and immunology department in Qatar
  34. Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
  35. Case report: Challenges in the diagnosis of Eosinophilic esophagitis
  36. Circulating microRNA signatures in patients with chronic Urticaria
  37. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
  38. The Second Qatar Allergy and Immunology Conference: An Editorial
  39. The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
  40. Predictors of Early Death Among Untransplanted Patients with Combined immunodeficiencies affecting cellular and humoral immunity
  41. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity
  42. Predictors of early death risk among untransplanted patients with combined immunodeficiencies affecting cellular and humoral immunity: A multicenter report
  43. Anaphylaxis after prick‐to‐prick skin test to seafood allergy: A rare adverse event
  44. BCG Vaccine–associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity
  45. Aerobiological monitoring in a desert type ecosystem: Two sampling stations of two cities (2017–2020) in Qatar
  46. Digital tools in allergy and respiratory care
  47. Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
  48. Contributions of nurse specialists in the allergy and immunology service and patient care
  49. Do we need aerobiological air monitoring in desert climates? The Qatar experience
  50. Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
  51. Severity and outcome of COVID-19 disease in patients with allergic rhinitis during the pandemic in Qatar – A preliminary report
  52. Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease
  53. Aspirin challenge and desensitization in patients with suspected AERD in Qatar
  54. Circulatory EVs as a predictor of chronic urticarial activity
  55. First allergy conference in Qatar: Let's explore allergy with a new lens
  56. Real-world experience of the clinical effectiveness of omalizumab use in Qatar – a study protocol
  57. SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
  58. Correlation between skin test results and historical manifestations in patients with suspected lidocaine hypersensitivity
  59. First volumetric records of airborne Cladosporium and Alternaria spores in the atmosphere of Al Khor (northern Qatar): a preliminary survey
  60. Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
  61. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study
  62. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  63. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  64. The correlation between middle schoolchildren allergic symptoms and airborne particle season
  65. Viral exanthem following influenza vaccine
  66. A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar
  67. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
  68. Auto-Immunoproteomics Analysis of COVID-19 ICU Patients Revealed Increased Levels of Autoantibodies Related to Male Reproductive System
  69. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
  70. Association of endometriosis with interstitial cystitis in chronic pelvic pain syndrome: Short narrative on prevalence, diagnostic limitations, and clinical implications
  71. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  72. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  73. Abstract 13039: Putative Protective Effects Of Caffeine And Its Metabolites On Coronary Heart Disease In The Middle East
  74. Abstract 13041: Differences In Systemic Fatty Acids Between Coronary Heart Disease Patients And Controls From The Middle East Favors Inflammation
  75. Primary immunodeficiency and the microbiome
  76. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection
  77. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
  78. METABOLOMICS REVEALS PERTURBATIONS IN ARGININE-NO METABOLISM, PURINE BIOSYNTHESIS AND CELLULAR ENERGY CHARGE IN PATIENTS WITH CORONARY HEART DISEASE
  79. REPRODUCTIBILITY OF A METABOLITE RISK SCORE TO PREDICT CORONARY HEART DISEASE IN A MIDDLE EASTERN POPULATION
  80. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
  81. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications
  82. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
  83. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
  84. A founder RAB27A variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families
  85. The association between airborne pollen monitoring and sensitization in the hot desert climate
  86. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  87. Immunogenetics of Celiac Disease: A Focus on Arab Countries
  88. The Association Between Airborne Pollen Monitoring and Sensitization in the Hot Desert Climate
  89. Etiology and outcome of hemoptysis in Qatar, a high-resource country with a large expatriate population: A retrospective study
  90. A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
  91. Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study
  92. Delayed clavulanic acid–induced anaphylaxis in a patient undergoing bariatric surgery
  93. Complex Regional Pain Syndrome Type I Following Tetanus Toxoid Injection
  94. Two cases of food-dependent exercise-induced anaphylaxis with different culprit foods
  95. Renal allograft tuberculosis with infected lymphocele transmitted from the donor
  96. Primary Cutaneous Vasculitis Masquerading as Drug Induced following Aspirin Desensitization
  97. Two Cases of Recurrent Episodes of Angio Edema Without Urticaria or Pruritus
  98. Prevalence of Pharmacogenetic Risk Alleles in a Consanguineous Middle Eastern Population.